Imran Mohammed Yousuf - 15 Aug 2025 Form 4 Insider Report for Health In Tech, Inc. (HIT)

Reporting relationship: Chief Technology Officer
Issuer ticker: HIT
Reported as of: 15 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Aug 2025, 19:00:05 UTC
Prior SEC filing: 20 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Imran Yousuf

Key filing fact

Imran Mohammed Yousuf filed Form 4 for Health In Tech, Inc. (HIT) on 19 Aug 2025.

Key facts

This page summarizes Imran Mohammed Yousuf's Form 4 filing for Health In Tech, Inc. (HIT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Aug 2025, 19:00.

Change

Previous filing in this sequence was filed on 20 Dec 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002041942 Primary reporting owner

Yousuf Imran Mohammed

Relationship: Chief Technology Officer
Address: 701 S. COLORADO AVE, SUITE 1, STUART
Signature: /s/ Imran Yousuf
Signature date: 19 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIT transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +7,000
Change %: +7%
Price: $0.000000
Shares after: 107,000
Date: 15 Aug 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Fifty percent (50%) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of two specified programs being developed by the Company is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other specified program being developed by the Company is successfully launched and fully operational in the marketplace.

Footnote F2

Includes 100,000 shares of Class A Common Stock and 7,000 shares of restricted stock. Excludes 100,000 options to purchase shares of Class A Common Stock.